Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in
hair loss, that affects up to 2% of the general population. The exact pathobiology of AA has …

Alopecia areata is an autoimmune hair loss disease that is non-scarring and is
characterized by chronic inflammation at the hair follicle level. Clinically, patients' …

Alopecia areata (AA) is a chronic, immune‐mediated disease characterized by acute or
chronic non‐scarring hair loss, with a heterogeneity in clinical manifestations ranging from …

Background: Alopecia areata is a highly frequent disease with an impact on quality of life
and several treatment options with little clinical confirmatory evidence. Objective: To …

Cytotoxic T lymphocyte has been a concern for the etiopathogenesis of alopecia areata
(AA), some recent evidence suggests that the regulatory T (Treg) cell deficiency is also a …

Introduction Alopecia areata is a heterogenous, immune-mediated hair loss disorder that
can affect any hair-bearing site on the body. Despite being one of the most prevalent …

Alopecia areata (AA) is nonscarring hair loss characterized by Th1 and concomitant Th2
skewing, particularly in atopic patients. Despite novel developments for adult AA, safe and …

Oleanolic acid (OA) is a pentacyclic triterpenoid with favourable physiological activity. It is
widely distributed in more than 200 species of plants. OA has garnered significant interest …

Introduction Alopecia, encompassing non-scarring and scarring types, presents therapeutic
challenges requiring individualized approaches based on pathophysiology and treatment …

Background Alopecia areata (AA), an autoimmune disorder characterized by hair loss, can
be particularly difficult to manage when patients do not respond to standard therapeutic …